{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:37Z","timestamp":1789506637935,"version":"build-2803163510"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128919","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:46:18Z","timestamp":1784666778000},"page":"128919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acute intraocular inflammation: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-7771","authenticated-orcid":false,"given":"Steven","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-0640","authenticated-orcid":false,"given":"Wanjiku","family":"Mathenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-5885","authenticated-orcid":false,"given":"Jean-Claude","family":"Mwanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3286-6845","authenticated-orcid":false,"given":"Supriya","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kaftan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7722-2486","authenticated-orcid":false,"given":"Hammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4220-2702","authenticated-orcid":false,"given":"Barbara","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128919_bb0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jama.2025.4358","article-title":"Uveitis in adults: a review","volume":"334","author":"Maghsoudlou","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128919_bb0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/ceo.14175","article-title":"The standardisation of uveitis nomenclature (SUN) project","volume":"50","author":"Jabs","year":"2022","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2013.03.027","article-title":"Approach to the diagnosis of the uveitides","volume":"156","author":"Jabs","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100082","article-title":"Managing a patient with uveitis in the era of artificial intelligence: current approaches, emerging trends, and future perspectives","volume":"13","author":"Rojas-Carabali","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.vaccine.2026.128919_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.survophthal.2020.05.004","article-title":"Retinal vasculitis: a framework and proposal for a classification system","volume":"66","author":"Datoo O\u2019Keefe","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working Group","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pds.851","article-title":"The Brighton Collaboration: enhancing comparability of vaccine safety data","volume":"12","author":"Kohl","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2026.128919_bb0040","series-title":"Advances in patient safety: from research to implementation (volume 2: concepts and methodology)","article-title":"Advances in patient safety. The Brighton Collaboration: creating a global standard for case definitions (and guidelines) for adverse events following immunization","author":"Kohl","year":"2005"},{"key":"10.1016\/j.vaccine.2026.128919_bb0045","unstructured":"Law B, Ali H, Sturkenboom M, Rojo Villaescusa M for SPEAC (Safety Platform for Emergency vACcines) Project. Case Definition Companion Guide for Acute Intraocular Inflammation (aIOI), Version 1.0, 2026; https:\/\/doi.org\/10.5281\/zenodo.21415840: 1-98. Last accessed 17 July 2026."},{"key":"10.1016\/j.vaccine.2026.128919_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09286586.2021.1882506","article-title":"Prevalence and incidence of uveitis: a systematic review and meta-analysis","volume":"28","author":"Garcia-Aparicio","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0060","first-page":"6658","article-title":"Measuring the incidence and prevalence of uveitis and scleritis in a national medical claims database","volume":"60","author":"Amin","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2026.128919_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2026.128919_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2025.03.032","article-title":"Incidence and prevalence of uveitis and associated ocular complications in the United States TriNetX database","volume":"276","author":"Kirupaharan","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"307","key":"10.1016\/j.vaccine.2026.128919_bb0075","article-title":"Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort","volume":"113","author":"Reeves","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2026.128919_bb0080","first-page":"2862","article-title":"Epidemiology of uveitis in the United States","volume":"66","author":"Sohn","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"890\u20136","key":"10.1016\/j.vaccine.2026.128919_bb0085","article-title":"Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest","volume":"146","author":"Suhler","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/09273948.2021.1988113","article-title":"Epidemiology of uveitis in Olmsted County, Minnesota: a population-based follow-up study","volume":"31","author":"Xu","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/aos.14130","article-title":"Epidemiology of uveitis in a region of southern Sweden","volume":"98","author":"Bro","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0100","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.jval.2023.09.1133","article-title":"The incidence of uveitis in the United Kingdom 2004-2021","volume":"26","author":"Buxton","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2026.128919_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08820538.2021.1885721","article-title":"Epidemiology of uveitis in a tertiary care centre in Portugal","volume":"36","author":"Hermann","year":"2021","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1034\/j.1600-0420.2001.079001064.x","article-title":"Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases","volume":"79","author":"Mercanti","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.vaccine.2026.128919_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00917833","article-title":"Epidemiological characteristics of uveitis in Switzerland","volume":"18","author":"Tran","year":"1994","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41433-024-03500-8","article-title":"Trends in nationwide incidence of uveitis in South Korea using the National Health Insurance claims database from 2010 to 2021","volume":"39","author":"Hong","year":"2025","journal-title":"Eye (London)"},{"key":"10.1016\/j.vaccine.2026.128919_bb0125","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1080\/09273948.2025.2524587","article-title":"Nationwide trends in the incidence and use of immunosuppressive therapy for non-infectious non-anterior uveitis in South Korea (2010-2021)","volume":"33","author":"Hwang","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0130","first-page":"1","article-title":"Patterns of uveitis among Nepalese population presenting at a Tertiary Referral Eye Care Centre in Nepal","volume":"5","author":"Kharel","year":"2019","journal-title":"New Front Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bjophthalmol-2016-309829","article-title":"Incidence and prevalence of uveitis in South Korea: a nationwide cohort study","volume":"102","author":"Rim","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0140","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1080\/09273948.2016.1236971","article-title":"Epidemiology and clinical features of uveitis from urban populations in South India","volume":"25","author":"Sabhapandit","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0145","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.4103\/ijo.IJO_1122_21","article-title":"LV Prasad Eye Institute EyeSmart electronic medical record-based analytics of big data: LEAD-Uveitis Report 1: demographics and clinical features of uveitis in a multi-tier hospital based network in Southern India","volume":"70","author":"Tyagi","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/09286580802478724","article-title":"Epidemiology of uveitis","volume":"15","author":"Jabs","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12969-021-00516-2","article-title":"Epidemiology of pediatric uveitis and associated systemic diseases","volume":"19","author":"Shin","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.vaccine.2026.128919_bb0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12348-024-00444-8","article-title":"Infectious uveitis: a comprehensive systematic review of emerging trends and molecular pathogenesis using network analysis","volume":"14","author":"Asghar","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.vaccine.2026.128919_bb0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/IIO.0b013e3181d2cf2e","article-title":"Arthropod vector-borne uveitis in the developing world","volume":"50","author":"Khairallah","year":"2010","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.vaccine.2026.128919_bb0170","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5301\/ejo.5000278","article-title":"Review on the worldwide epidemiology of uveitis","volume":"23","author":"Miserocchi","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004397-200004000-00011","article-title":"Infectious causes of uveitis in the developing world","volume":"40","author":"Rathinam","year":"2000","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.vaccine.2026.128919_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0185","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s10067-020-05362-3","article-title":"Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study","volume":"40","author":"Hassan","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10792-025-03555-w","article-title":"Non-infectious uveitis: a multicenter study from Argentina","volume":"45","author":"Virasoro","year":"2025","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0195","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1080\/09273948.2024.2367676","article-title":"Vitamin D levels in patients with noninfectious uveitis: a systematic review and meta-analysis","volume":"32","author":"Cunha Amaral","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09273948.2025.2574484","article-title":"Smoking and risk of uveitis: a systematic review and meta-analysis","volume":"34","author":"Kuc","year":"2026","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0205","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ophtha.2015.02.034","article-title":"Association between smoking and uveitis: results from the Pacific Ocular Inflammation Study","volume":"122","author":"Yuen","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2026.128919_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100474","article-title":"Risk of recurrent noninfectious uveitis after coronavirus disease 2019 vaccination in the United States","volume":"4","author":"Kumar","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.vaccine.2026.128919_bb0215","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2022.05.015","article-title":"Association between vaccination with the BNT162b2 mRNA coronavirus disease 2019 vaccine and noninfectious uveitis: a population-based study","volume":"129","author":"Tomkins-Netzer","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2026.128919_bb0220","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2022.12.013","article-title":"Navigating coronavirus disease 2019 vaccination and uveitis: identifying the rates and risk of recurrent uveitis after coronavirus disease vaccination","volume":"130","author":"Jordan","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2026.128919_bb0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55804","article-title":"Early vs deferred non-messenger RNA COVID-19 vaccination among chinese patients with a history of inactive uveitis: a randomized clinical trial","volume":"6","author":"Zhong","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128919_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajo.2023.09.015","article-title":"Noninfectious uveitis risk after COVID-19 vaccination: a nationwide retrospective cohort study","volume":"258","author":"Chang","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0235","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/09286586.2023.2289990","article-title":"Ocular adverse events after influenza vaccination in older adults: self-controlled case series using a large database in Japan","volume":"31","author":"Hashimoto","year":"2024","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0240","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/bjo-2024-325985","article-title":"Global burden of vaccine-associated uveitis and their related vaccines, 1967-2023","volume":"109","author":"Oh","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(19)30614-0","article-title":"Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Clarke","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128919_bb0250","first-page":"1","article-title":"Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)","author":"Miller","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128919_bb0255","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128919_bb0260","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1016\/j.vaccine.2018.12.026","article-title":"An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus vaccine, HydroVax-001, in healthy adults","volume":"37","author":"Woods","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128919_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2385","article-title":"Safety and immunogenicity of Zika virus vaccine: a systematic review of clinical trials","volume":"33","author":"Yeasmin","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12879-020-4838-x","article-title":"Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report","volume":"20","author":"Volkov","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128919_bb0275","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0002-9394(99)00059-8","article-title":"Uveitis associated with varicella virus vaccine","volume":"127","author":"Esmaeli-Gutstein","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"282\u20133","key":"10.1016\/j.vaccine.2026.128919_bb0280","first-page":"363","article-title":"Acute posterior multifocal placoid pigment epitheliopathy following varicella vaccination","volume":"94","author":"Fine","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0285","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archophthalmol.2011.1881","article-title":"Uveitis exacerbation after varicella-zoster vaccination in an adult","volume":"130","author":"Sham","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0290","article-title":"Uveitis reactivation following recombinant zoster vaccination","volume":"23","author":"Richards","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.vaccine.2026.128919_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1567164","article-title":"Post-varicella vaccination uveitis in a child with nephrotic syndrome receiving immunosuppressive treatment: a case report","volume":"13","author":"Andrade","year":"2025","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2026.128919_bb0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12348-025-00508-3","article-title":"Unilateral uveitis following adjuvanted Varicella-Zoster subunit vaccine in a patient with previously resolved Varicella Zoster acute retinal necrosis","volume":"15","author":"Trinco","year":"2025","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.vaccine.2026.128919_bb0305","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3928\/01913913-20080701-15","article-title":"Chronic anterior uveitis following bacille Calmette-Gu\u00e9rin vaccination: molecular mimicry in action?","volume":"45","author":"Spratt","year":"2008","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.vaccine.2026.128919_bb0310","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1080\/09273948.2025.2551802","article-title":"Acute posterior multifocal placoid pigment epitheliopathy-like panuveitis following mpox vaccination","volume":"33","author":"Lu","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12348-025-00455-z","article-title":"Sudden bilateral vision loss: a case report of frosted branch angiitis following pentavalent vaccination in a 2-year-old boy","volume":"15","author":"Aljasir","year":"2025","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.vaccine.2026.128919_bb0320","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-0420.2000.078005590.x","article-title":"Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases","volume":"78","author":"Islam","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.vaccine.2026.128919_bb0325","first-page":"470","article-title":"Panuveitis and dermal vasculitis following MMR vaccination","volume":"13","author":"Sedaghat","year":"2007","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2026.128919_bb0330","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1442-9071.2005.00995.x","article-title":"Acute posterior multifocal placoid pigment epitheliopathy after meningococcal C conjugate vaccine","volume":"33","author":"Yang","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.128919_bb0335","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/ICB.0000000000000391","article-title":"The second blind spot: small retinal vessel vasculopathy after vaccination against neisseria meningeitis and yellow fever","volume":"11","author":"Moysidis","year":"2017","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.vaccine.2026.128919_bb0340","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2415-5-20","article-title":"Bilateral neuro-retinitis following chick embryo cell anti-rabies vaccination--a case report","volume":"5","author":"Saxena","year":"2005","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0345","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12886-018-0968-y","article-title":"Multiple evanescent white dot syndrome following rabies vaccination: a case report","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09273948.2014.925126","article-title":"Rubella virus-associated anterior uveitis in a vaccinated patient: a case report","volume":"24","author":"ten Berge","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0355","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ophtha.2022.08.027","article-title":"Vaccine-associated uveitis after COVID-19 vaccination: vaccine adverse event reporting system database analysis","volume":"130","author":"Singh","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2026.128919_bb0360","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10238-022-00954-6","article-title":"Pathogenesis and current therapies for non-infectious uveitis","volume":"23","author":"Wu","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.vaccine.2026.128919_bb0365","doi-asserted-by":"crossref","first-page":"163","DOI":"10.31348\/2021\/07","article-title":"Immune-mediated intraocular inflammation. A review","volume":"77","author":"Kl\u00edmov\u00e1","year":"2021","journal-title":"Cesk Slov Oftalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0370","first-page":"1050","article-title":"Cultivated corneal endothelial cell sheet transplantation in a primate model","volume":"113","author":"Koizumi","year":"2009","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.vaccine.2026.128919_bb0375","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/09286586.2024.2343714","article-title":"Incidence and association of uveitis with COVID-19 vaccination: a systematic review and meta-analysis","volume":"32","author":"Padhi","year":"2025","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656362","article-title":"How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: an expert opinion by IMIDs Study Group","volume":"12","author":"Ferretti","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0385","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000521785","article-title":"Uveitis after COVID-19 vaccination","volume":"13","author":"Hwang","year":"2022","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0390","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12348-023-00358-x","article-title":"Ocular manifestations following COVID-19 vaccination","volume":"13","author":"Mahendradas","year":"2023","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.vaccine.2026.128919_bb0395","first-page":"112","article-title":"Uveitis: classification, diagnosis, and treatment","volume":"4","author":"Elaska","year":"2021","journal-title":"Am J Res Rep Opthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.046","article-title":"Applicability of selected Brighton Collaboration case definitions in low-resource settings: a prospective hospital-based active surveillance in Addis Ababa, Ethiopia","volume":"42","author":"Sintayehu","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128919_bb0405","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.vaccine.2008.11.036","article-title":"Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128919_bb0410","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.vaccine.2008.11.035","article-title":"Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128919_bb0415","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/OPTH.S80972","article-title":"Epidemiology of uveitis in the mid-Atlantic United States","volume":"9","author":"Bajwa","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0420","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/09273948.2024.2408411","article-title":"Epidemiology of intermediate uveitis","volume":"33","author":"Besagar","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0425","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis subtypes in a German interdisciplinary uveitis center--analysis of 1916 patients","volume":"36","author":"Jakob","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0430","first-page":"233","article-title":"Patterns of uveitis in the middle East and Europe","volume":"6","author":"Nashtaei","year":"2011","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.vaccine.2026.128919_bb0435","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09286586.2020.1815802","article-title":"Epidemiology of uveitis in a Spanish region: prevalence and etiology","volume":"28","author":"Garcia-Aparicio","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0440","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00417-024-06422-z","article-title":"Epidemiology, clinical features, and classification of 3,404 patients with uveitis: Colombian Uveitis Multicenter Study (COL-UVEA)","volume":"262","author":"de-la Torre","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0445","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1080\/09273948.2017.1335755","article-title":"Review of epidemiology of uveitis in Asia: pattern of uveitis in a tertiary hospital in the Philippines","volume":"25","author":"Abano","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0450","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1080\/09273948.2016.1189577","article-title":"Patterns and etiologies of uveitis at a tertiary referral center in Taiwan","volume":"25","author":"Chen","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0455","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/09273948.2014.1002567","article-title":"Spectrum of uveitis in a German tertiary center: review of 474 consecutive patients","volume":"23","author":"Grajewski","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0460","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1442-9071.2009.02102.x","article-title":"Frequency and clinical features of intraocular inflammation in Tokyo","volume":"37","author":"Keino","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100199","article-title":"Programme for ocular inflammation & infection translational research (PROTON) registry: cross-sectional analysis of baseline patient characteristics","volume":"14","author":"Rojas-Carabali","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.vaccine.2026.128919_bb0470","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1080\/09273948.2016.1188968","article-title":"The pattern of uveitis among Chinese, Malays, and Indians in Singapore","volume":"25","author":"Siak","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0475","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2147\/OPTH.S273938","article-title":"Clinical features of japanese patients with ocular inflammation and their surgical procedures over the course of 20 years","volume":"14","author":"Takai","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0480","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1080\/09273948.2017.1313991","article-title":"The pattern of uveitis in Sri Lanka","volume":"25","author":"Siak","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0485","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1080\/09273948.2016.1231826","article-title":"The spectrum of uveitis in Southern Vietnam","volume":"25","author":"Nguyen","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0490","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.survophthal.2025.04.001","article-title":"Clinical features of retinal vasculitis: a systematic review and meta-analysis from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3","volume":"70","author":"Cifuentes-Gonz\u00e1lez","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0495","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.semarthrit.2011.10.006","article-title":"Patients with retinal vasculitis rarely suffer from systemic vasculitis","volume":"41","author":"Rosenbaum","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2026.128919_bb0500","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/0301-4738.58469","article-title":"Intermediate uveitis","volume":"58","author":"Babu","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0505","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajo.2007.08.023","article-title":"Pars planitis: a 20-year study of incidence, clinical features, and outcomes","volume":"144","author":"Donaldson","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0510","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000429625","article-title":"Epidemiology of intermediate uveitis: a prospective study in Savoy","volume":"23","author":"Vadot","year":"1992","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0515","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2990.2003.00499.x","article-title":"The pathology and pathogenesis of retinal vasculitis","volume":"29","author":"Hughes","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0520","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bjo.84.7.706","article-title":"Population based assessment of uveitis in an urban population in southern India","volume":"84","author":"Dandona","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0525","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1080\/09273948.2016.1255761","article-title":"Epidemiology of uveitis in a tertiary-care referral institute in North India","volume":"25","author":"Dogra","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0530","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1080\/09273948.2016.1215475","article-title":"Pattern of uveitis in a tertiary ophthalmology center in Thailand","volume":"25","author":"Sukavatcharin","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0535","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","article-title":"Prevalence of noninfectious uveitis in the United States: a claims-based analysis","volume":"134","author":"Thorne","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0540","first-page":"15","article-title":"Epidemiology of uveitis from a tertiary referral hospital in Bulgaria over a 13-year period","author":"Mitkova-Hristova","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.vaccine.2026.128919_bb0545","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1167\/iovs.15-16645","article-title":"Complement C5 gene confers risk for acute anterior uveitis","volume":"56","author":"Xu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2026.128919_bb0550","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/08820530500232035","article-title":"Intermediate uveitis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0555","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.survophthal.2025.01.012","article-title":"Global demographic and etiological variations of retinal vasculitis: a systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1","volume":"70","author":"Cifuentes-Gonz\u00e1lez","year":"2025","journal-title":"Surv Ophthalmol"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2026.128919_bb0560","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/eye.1992.66","article-title":"Ocular manifestations of Noonan syndrome","volume":"6","author":"Lee","year":"1992","journal-title":"Eye (London)"},{"key":"10.1016\/j.vaccine.2026.128919_bb0565","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/09273948.2016.1175642","article-title":"Review for disease of the year: epidemiology of HLA-B27 associated ocular disorders","volume":"24","author":"Kopplin","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0570","series-title":"HLA-B27 syndromes","author":"Parameswaran","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128919_bb0575","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.ophtha.2024.06.003","article-title":"Risk of recurrence in acute anterior uveitis","volume":"131","author":"Brodie","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2026.128919_bb0580","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09273948.2019.1569239","article-title":"Ocular features in Chinese patients with blau syndrome","volume":"28","author":"Wu","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0585","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2015.12.034","article-title":"Remission of intermediate uveitis: incidence and predictive factors","volume":"164","author":"Kempen","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0590","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4274\/tjo.35555","article-title":"Peripheral vasculitis, intermediate uveitis and interferon use in multiple sclerosis","volume":"46","author":"Kinyas","year":"2016","journal-title":"Turk J Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0595","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/aos.14697","article-title":"Insights into multiple sclerosis-associated uveitis: a scoping review","volume":"99","author":"Casselman","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0600","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20209118","article-title":"Evaluation of factors for predicting risk of uveitis recurrence in Behcet\u2019s disease patients","volume":"53","author":"Cai","year":"2020","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2026.128919_bb0605","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/09273940591003828","article-title":"Retinal vasculitis","volume":"13","author":"Abu El-Asrar","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0610","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1442-9071.2010.02298.x","article-title":"Recurrent idiopathic neuroretinitis: natural history and effect of treatment","volume":"38","author":"Sundaram","year":"2010","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0615","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNO.0b013e31820cf78a","article-title":"Neuroretinitis: review of the literature and new observations","volume":"31","author":"Purvin","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0620","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archopht.121.1.65","article-title":"Idiopathic recurrent neuroretinitis: effects of long-term immunosuppression","volume":"121","author":"Purvin","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0625","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.oftal.2025.01.010","article-title":"Infectious uveitis: epidemiology, etiology, diagnostic test performance and treatment","volume":"100","author":"M\u00e9ndez-Rodr\u00edguez","year":"2025","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"10.1016\/j.vaccine.2026.128919_bb0630","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.survophthal.2023.12.003","article-title":"Causes of infectious pediatric uveitis: a review","volume":"69","author":"Ngathaweesuk","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640473","article-title":"Pathogenesis of non-infectious uveitis elucidated by recent genetic findings","volume":"12","author":"Takeuchi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128919_bb0640","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11882-013-0409-1","article-title":"Noninfectious immune-mediated uveitis and ocular inflammation","volume":"14","author":"Pan","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.vaccine.2026.128919_bb0645","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/09273948.2023.2190801","article-title":"Prevalence of ocular toxoplasmosis in the general population and uveitis patients: a systematic review and meta-analysis","volume":"32","author":"Karami","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.vaccine.2026.128919_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091533","article-title":"Trends in patterns of intermediate uveitis in a tertiary institution in Singapore","volume":"9","author":"Mi","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2026.128919_bb0655","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13023-017-0638-9","article-title":"Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center","volume":"12","author":"Ness","year":"2017","journal-title":"Orphanet J Rare Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:33:31Z","timestamp":1789504411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":131,"alternative-id":["S0264410X26007280"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128919","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute intraocular inflammation: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128919"}}